Company Profiles

driven by the PitchBook Platform

Andes Biotechnologies

Andes Biotechnologies
2008 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Later Stage VC LATEST DEAL TYPE (In Progress)
$2.17M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer novel therapeutics intended to use the potential of non-coding RNAs and antisense technologies to create a new class of drugs for the treatment of cancer. The company's novel therapeutics utilize proprietary technology to target the novel long non-coding regulatory RNAs in tumor cells inducing apoptosis, enabling physicians to selectively destroys cancer cells without affecting normal cells.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Parque Tecnológico Zañartu
  • Av. Zañartu, Ñuñoa
  • Santiago, 1482
  • Chile

+56 000000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Andes Biotechnologies’s full profile, request a free trial.

Andes Biotechnologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 15-Dec-2017 $2.17M 000.00 In Progress Clinical Trials - General
5. Later Stage VC (Series B) 15-Apr-2015 0000 000.00 Completed Clinical Trials - General
4. Later Stage VC 10-Mar-2014 00000 00.000 Completed Clinical Trials - General
3. Early Stage VC 10-May-2012 00000 00.00 Completed Clinical Trials - General
2. Early Stage VC (Series A) 19-May-2011 $4M $4M Completed Clinical Trials - General
1. Grant 11-Jan-2011 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Andes Biotechnologies Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Aurus Capital Venture Capital Minority 000 0000 000000 0
Austral Capital Partners Venture Capital Minority 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator Minority 000 0000 000000 0

Andes Biotechnologies Executive Team (4)

Name Title Board
Seat
Contact
Info
Pablo Valenzuela Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Cristian Hernandez-Cuevas Chief Operating Officer
Luis Burzio Ph.D Co-Founder, Chief Scientific Officer, Head of Preclinical Research & Board Member
Patricio Caceres Head, Finance and Human Resources

Andes Biotechnologies Board Members (7)

Name Representing Role Since Contact
Info
Ahmed Hamdy MD Self Board Member & Clinical Advisor 000 0000
Alexander Seelenberger Aurus Capital Board Member 000 0000
Arturo Yudelevich Ph.D Self Board Member 000 0000
Gonzalo Miranda Austral Capital Partners Board Member 000 0000
Luis Burzio Ph.D Andes Biotechnologies Co-Founder, Chief Scientific Officer, Head of Preclinical Research & Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 7 board members. Get the full list »